We would like to address several issues that arise from the study by Muftuoglu et al (1).
1. Several relevant data are missing from the study (Tab. I). 2. The study was retrospectively conducted with a relatively small sample size of patients with diabetic macular edema (DME). 3. There was a selection bias attributable to inclusion and comparison of 2 completely different groups of eyes (e.g., initial damage group and always damage group) with definite differences regarding the following baseline features: hyperlipidemia (58.82% and 90.90%, respectively), subfoveal hard exudates (50% and 65.2%, respectively), duration of DME (15.8 and 28.6 weeks, respectively), visual acuity (0.37 and 0.54 logarithm of minimum angle of resolution [logMAR], respectively), disruption of the external limiting membrane (ELM) (2.4% and 22.9%, respectively), disruption of the inner segment/outer segment (IS/OS) junction layer (10.7% and 23.6%, respectively), central subfield thickness (338 and 398 µm, respectively), and maximum retinal thickness (430 and 489 µm, respectively). Notably, the DME was in a less progressed stage of evolution in patients of the initial damage group (e.g., less hyperlipidemia and hard exudates, shorter duration of DME, better visual acuity, fewer damage to the ELM and IS/OS junction layer, and thinner macula) in comparison with those in the always damage group. Moreover, various treatments were administered, including bevacizumab (Avastin; Genentech) and/or steroid (triamcinolone acetonide; Kenalog; Bayer-Bristol) intravitreal injections with or without additional macular laser. Taken together, these findings may have confounded the results. 4. There were no details regarding the DME defined as retinal thickening (focal/multifocal/diffuse) or subfoveal hard exudates at or within 1 disk diameter of the center of the macula and which is most commonly classified into either being clinically significant (CSME) or not (2) . Furthermore, the criteria used to define the CSME, if it was present in some patients, were not indicated. 5. Unlike the favorable final results in the patients of the initial damage group (e.g., a vision gain of 0.25 logMAR and complete restoration of the ELM and IS/OS junction layer disruptions), the final outcomes in the patients of the always damage group were unsatisfactory. Specifically, there was a vision gain of 0.01 logMAR and an increase in the ELM and IS/OS junction damage from 22.9% to 23.6% and from 23.6% to 24.2%, respectively. Potential reasons for these suboptimal visual and anatomical outcomes include multiple factors. Most likely, there was a permanent vascular endothelial growth factor (VEGF) receptor 2-mediated breakdown of the inner blood-retinal barrier and a permanent VEGF receptor 1-mediated rupture of the retinal pigment epithelium junctions induced by long-term VEGF overexpression and high vitreous levels of placental growth factor in patients with DME (3). This permanent retinal capillaropathy caused by long-standing duration of DME (28.6 weeks) and diabetes (17.7 years) was temporarily relieved by reduction of the edematous component with antiangiogenic agents (4) . However, the pathology was incurable owing to irreversible ischemic changes to the macular ganglion cell complex, close to foveola, with macular edema being a minor factor (2, 5). 6. The statistical analysis would have had to include the following critical baseline data in addition to the baseline characteristics already mentioned by the authors, serving as potential prognosticators for the restoration of photoreceptors and vision improvement: anatomic type of DME, prevalence of CSME, qualitative status of the interdigitation zone and retinal pigment epithelial band, prevalence of vitreoretinal interface abnormalities, quantification of subretinal drusenoid deposits, subfoveal choroidal thickness, and fluorescein angiographic findings. In the end, the statistically significant variables should have been selected for the final model.
Altogether, the authors of this study substantiated 2 potential prognosticators (e.g., shorter duration of DME and less baseline IS/OS damage) for the restoration of the IS/OS junction layer and visual improvement. Conceivably, their number would have been higher if all the baseline features that we mentioned had been also included in the stepwise linear regression model after adjustment for the baseline differences.
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